8-142912850-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000498.3(CYP11B2):​c.1157T>C​(p.Val386Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,597,830 control chromosomes in the GnomAD database, including 10,505 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. V386V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.088 ( 713 hom., cov: 32)
Exomes 𝑓: 0.11 ( 9792 hom. )

Consequence

CYP11B2
NM_000498.3 missense

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 0.379

Publications

38 publications found
Variant links:
Genes affected
CYP11B2 (HGNC:2592): (cytochrome P450 family 11 subfamily B member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane. The enzyme has steroid 18-hydroxylase activity to synthesize aldosterone and 18-oxocortisol as well as steroid 11 beta-hydroxylase activity. Mutations in this gene cause corticosterone methyl oxidase deficiency. [provided by RefSeq, Jul 2008]
GML (HGNC:4375): (glycosylphosphatidylinositol anchored molecule like) Predicted to be involved in DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; apoptotic process; and negative regulation of cell population proliferation. Predicted to be extrinsic component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0076085925).
BP6
Variant 8-142912850-A-G is Benign according to our data. Variant chr8-142912850-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 242772.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.117 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000498.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP11B2
NM_000498.3
MANE Select
c.1157T>Cp.Val386Ala
missense
Exon 7 of 9NP_000489.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP11B2
ENST00000323110.2
TSL:1 MANE Select
c.1157T>Cp.Val386Ala
missense
Exon 7 of 9ENSP00000325822.2
GML
ENST00000522728.5
TSL:3
c.182-1113A>G
intron
N/AENSP00000430799.1

Frequencies

GnomAD3 genomes
AF:
0.0883
AC:
13358
AN:
151294
Hom.:
711
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0410
Gnomad AMI
AF:
0.0615
Gnomad AMR
AF:
0.0790
Gnomad ASJ
AF:
0.134
Gnomad EAS
AF:
0.00290
Gnomad SAS
AF:
0.108
Gnomad FIN
AF:
0.0992
Gnomad MID
AF:
0.170
Gnomad NFE
AF:
0.120
Gnomad OTH
AF:
0.103
GnomAD2 exomes
AF:
0.0845
AC:
20671
AN:
244568
AF XY:
0.0885
show subpopulations
Gnomad AFR exome
AF:
0.0284
Gnomad AMR exome
AF:
0.0546
Gnomad ASJ exome
AF:
0.116
Gnomad EAS exome
AF:
0.00125
Gnomad FIN exome
AF:
0.0910
Gnomad NFE exome
AF:
0.104
Gnomad OTH exome
AF:
0.0984
GnomAD4 exome
AF:
0.108
AC:
156905
AN:
1446418
Hom.:
9792
Cov.:
44
AF XY:
0.110
AC XY:
78858
AN XY:
719516
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0360
AC:
1193
AN:
33154
American (AMR)
AF:
0.0604
AC:
2681
AN:
44368
Ashkenazi Jewish (ASJ)
AF:
0.129
AC:
3338
AN:
25954
East Asian (EAS)
AF:
0.00101
AC:
40
AN:
39690
South Asian (SAS)
AF:
0.123
AC:
10546
AN:
85692
European-Finnish (FIN)
AF:
0.0955
AC:
5082
AN:
53220
Middle Eastern (MID)
AF:
0.156
AC:
873
AN:
5606
European-Non Finnish (NFE)
AF:
0.116
AC:
127187
AN:
1098876
Other (OTH)
AF:
0.0997
AC:
5965
AN:
59858
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.368
Heterozygous variant carriers
0
5756
11513
17269
23026
28782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4434
8868
13302
17736
22170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0883
AC:
13365
AN:
151412
Hom.:
713
Cov.:
32
AF XY:
0.0867
AC XY:
6415
AN XY:
73996
show subpopulations
African (AFR)
AF:
0.0410
AC:
1684
AN:
41056
American (AMR)
AF:
0.0789
AC:
1201
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.134
AC:
465
AN:
3470
East Asian (EAS)
AF:
0.00290
AC:
15
AN:
5168
South Asian (SAS)
AF:
0.108
AC:
517
AN:
4782
European-Finnish (FIN)
AF:
0.0992
AC:
1048
AN:
10568
Middle Eastern (MID)
AF:
0.176
AC:
51
AN:
290
European-Non Finnish (NFE)
AF:
0.120
AC:
8114
AN:
67848
Other (OTH)
AF:
0.102
AC:
214
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
528
1055
1583
2110
2638
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0822
Hom.:
320
ESP6500AA
AF:
0.0270
AC:
119
ESP6500EA
AF:
0.0955
AC:
821
ExAC
AF:
0.0887
AC:
10768

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Sep 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 20981092, 9703385, 27125267, 21237269, 1594605, 11174838, 22465514, 22995991, 10965212, 27884173, 7485152, 28190867, 16733366, 9814506, 30864636)

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Corticosterone methyloxidase type 2 deficiency Benign:2Other:1
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpretted as Pathogenic and reported on 05-03-2012 by Lab or GTR ID 504843. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.

Corticosterone 18-monooxygenase deficiency Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.

Feb 15, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Corticosterone 18-monooxygenase deficiency;C3463917:Corticosterone methyloxidase type 2 deficiency Benign:1
Jun 12, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glucocorticoid-remediable aldosteronism Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
2.5
DANN
Benign
0.53
DEOGEN2
Benign
0.17
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0058
N
LIST_S2
Benign
0.34
T
MetaRNN
Benign
0.0076
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.8
L
PhyloP100
0.38
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-1.7
N
REVEL
Uncertain
0.34
Sift
Benign
0.21
T
Sift4G
Benign
0.47
T
Polyphen
0.0
B
Vest4
0.015
MPC
0.28
ClinPred
0.0095
T
GERP RS
-2.4
Varity_R
0.19
gMVP
0.89
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61757294; hg19: chr8-143994266; COSMIC: COSV59994312; API